Assembly Biosciences Near Breakout; Key Clinical Trials in Focus
AI Prediction of Assembly Biosciences, Inc. (ASMB)
Assembly Biosciences, a clinical-stage biotech company focusing on hepatitis B cures, has shown promising developments in its drug pipeline and strategic collaborations. Given the upcoming clinical trial results and potential regulatory milestones, investors may find significant opportunities for growth.
ASMB Report Information
Prediction Date2025-07-03
Close @ Prediction$18.14
Mkt Cap465m
IPO DateN/a
AI-derived Information
Recent News for ASMB
- Apr 9, 8:00 am — Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026 (GlobeNewswire)
- Mar 19, 4:26 pm — Assembly Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
- Mar 19, 4:05 pm — Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights (GlobeNewswire)
- Mar 5, 5:30 pm — Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
- Feb 26, 5:30 pm — Personalis (PSNL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
- Feb 24, 9:55 pm — Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
- Dec 23, 10:45 am — GILD Exercises Option to License Assembly Bio's Herpes Programs (Zacks)
- Dec 22, 8:00 am — Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes (Business Wire)
- Dec 8, 4:05 pm — Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes (GlobeNewswire)
- Nov 10, 4:18 pm — Assembly Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
- Nov 10, 4:05 pm — Assembly Biosciences Reports Third Quarter 2025 Financial Results and Recent Updates (GlobeNewswire)
- Nov 7, 8:00 am — Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting (GlobeNewswire)
NDAPR (News-Driven AI Prediction Revision) events for ASMB
No NDAPR events found.
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.